Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ticagrelor-Based Dual Antiplatelet Therapy in Coronary Artery Bypass Grafting: A Randomized Clinical Trial on Graft Patency

NCT06981390 is registered in ClinicalTrials.gov with Kexiang Liu, MD as lead sponsor.

NCT NCT06981390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06981390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ticagrelor-Based Dual Antiplatelet Therapy in Coronary Artery Bypass Grafting: A Randomized Clinical Trial on Graft Patency
Lead sponsor
Kexiang Liu, MD
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
March 20, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass grafting, coronary artery disease, dual antiplatelet therapy, saphenous vein